DK1611173T3 - Polymere modificerende midler og farmaceutiske sammensætninger - Google Patents

Polymere modificerende midler og farmaceutiske sammensætninger

Info

Publication number
DK1611173T3
DK1611173T3 DK04723056T DK04723056T DK1611173T3 DK 1611173 T3 DK1611173 T3 DK 1611173T3 DK 04723056 T DK04723056 T DK 04723056T DK 04723056 T DK04723056 T DK 04723056T DK 1611173 T3 DK1611173 T3 DK 1611173T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
polymeric modifiers
modifiers
polymeric
pharmaceutical
Prior art date
Application number
DK04723056T
Other languages
Danish (da)
English (en)
Inventor
Yuji Kasuya
Masashi Honma
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of DK1611173T3 publication Critical patent/DK1611173T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/16—Monomers containing no hetero atoms other than the ether oxygen
    • C08F216/18—Acyclic compounds
    • C08F216/20—Monomers containing three or more carbon atoms in the unsaturated aliphatic radical
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/04—Anhydrides, e.g. cyclic anhydrides
    • C08F222/06—Maleic anhydride
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/1416—Monomers containing oxygen in addition to the ether oxygen, e.g. allyl glycidyl ether
    • C08F216/1425—Monomers containing side chains of polyether groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04723056T 2003-03-24 2004-03-24 Polymere modificerende midler og farmaceutiske sammensætninger DK1611173T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2003080389 2003-03-24
JP2003355853 2003-10-16
JP2003426598 2003-12-24
PCT/JP2004/004134 WO2004085500A1 (en) 2003-03-24 2004-03-24 Polymeric modifiers and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1611173T3 true DK1611173T3 (da) 2008-06-23

Family

ID=33101948

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04723056T DK1611173T3 (da) 2003-03-24 2004-03-24 Polymere modificerende midler og farmaceutiske sammensætninger

Country Status (23)

Country Link
US (1) US7811556B2 (de)
EP (1) EP1611173B1 (de)
KR (1) KR20050118201A (de)
AR (1) AR043917A1 (de)
AT (1) ATE388173T1 (de)
AU (1) AU2004223964B2 (de)
BR (1) BRPI0408526A (de)
CA (1) CA2520450C (de)
CL (1) CL2004000633A1 (de)
DE (1) DE602004012241T2 (de)
DK (1) DK1611173T3 (de)
ES (1) ES2301978T3 (de)
HK (1) HK1078598A1 (de)
IL (1) IL170489A (de)
MX (1) MXPA05010289A (de)
NZ (1) NZ542352A (de)
PA (1) PA8598701A1 (de)
PE (1) PE20041067A1 (de)
PL (1) PL1611173T3 (de)
PT (1) PT1611173E (de)
SI (1) SI1611173T1 (de)
TW (1) TWI293882B (de)
WO (1) WO2004085500A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2090599A1 (de) * 2008-02-13 2009-08-19 Construction Research and Technology GmbH Copolymer mit Polyetherseitenketten und Dicarbonsäurederivatbausteinen

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1217005A (en) 1916-05-08 1917-02-20 Judson D Mccarthy Photographic-printing frame.
DE3260845D1 (en) * 1981-01-16 1984-11-08 Nippon Catalytic Chem Ind Copolymer and method for manufacture thereof
JP2621308B2 (ja) 1987-03-13 1997-06-18 日本油脂株式会社 アリルエーテル−無水マレイン酸共重合体
JP2701295B2 (ja) 1987-03-13 1998-01-21 日本油脂株式会社 アリルエーテル−無水マレイン酸共重合体
JP2803265B2 (ja) 1989-12-26 1998-09-24 日本油脂株式会社 変性ポリペプチドおよびその用途
US5158622A (en) * 1991-02-12 1992-10-27 Betz Laboratories, Inc. Method and composition for treatment of aluminum
JP3271265B2 (ja) * 1991-03-07 2002-04-02 日本油脂株式会社 修飾プロテアーゼ
JP3035675B2 (ja) * 1991-08-21 2000-04-24 株式会社コーセー 修飾スーパーオキシドディスムターゼ
CA2080174A1 (en) 1991-10-11 1993-04-12 John E. Hayes Polymer polyol dispersants from polymers containing anhydride groups
JP3106265B2 (ja) 1992-05-26 2000-11-06 株式会社コーセー 修飾リゾチーム
US6004583A (en) 1995-03-22 1999-12-21 Orex Pharmaceutical Development Corp. Protein-containing polymer composition for oral administration
US6369027B1 (en) 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
IT1293087B1 (it) 1997-07-10 1999-02-11 Isi Ist Sierovaccinogeno Ital Microparticelle a base di materiali polimerici ibridi per il rilascio controllato di molecole biologicamente attive, procedimento per la
DE19834173A1 (de) * 1997-08-01 1999-02-04 Sueddeutsche Kalkstickstoff Copolymere auf Basis von ungesättigten Dicarbonsäure-Derivaten und Oxyalkylenglykol-Alkenylethern
JPH11302199A (ja) 1998-04-16 1999-11-02 Sankyo Co Ltd 薬物運搬体を構成するグラフト共重合体
DE19847868C2 (de) * 1998-10-16 2003-09-25 Clariant Gmbh Sprengstoffe, enthaltend modifizierte Copolymere aus Polyisobutylen und Maleinsäureanhydrid als Emulgatoren
CA2358463A1 (en) * 1999-01-08 2000-07-13 Virginia Commonwealth University Polymeric delivery agents and delivery agent compounds
ITTO20000942A1 (it) 2000-10-10 2001-01-10 Sergio Guzzoni Pricedimento per la gestione di interscambi di messaggi tra fornitorie clienti di servizi di telefonia.
JP2003105040A (ja) 2001-09-28 2003-04-09 Nof Corp 共重合体の製造方法およびその用途
JP5109218B2 (ja) 2001-09-28 2012-12-26 日油株式会社 共重合体の製造方法

Also Published As

Publication number Publication date
CL2004000633A1 (es) 2005-01-21
AU2004223964B2 (en) 2007-02-22
CA2520450A1 (en) 2004-10-07
AU2004223964A1 (en) 2004-10-07
EP1611173A1 (de) 2006-01-04
DE602004012241D1 (de) 2008-04-17
US20060062754A1 (en) 2006-03-23
EP1611173B1 (de) 2008-03-05
AR043917A1 (es) 2005-08-17
US7811556B2 (en) 2010-10-12
SI1611173T1 (sl) 2008-08-31
BRPI0408526A (pt) 2006-03-07
IL170489A (en) 2009-06-15
PL1611173T3 (pl) 2008-08-29
TW200501986A (en) 2005-01-16
PE20041067A1 (es) 2005-01-22
DE602004012241T2 (de) 2009-03-12
KR20050118201A (ko) 2005-12-15
PT1611173E (pt) 2008-05-23
TWI293882B (en) 2008-03-01
CA2520450C (en) 2009-11-03
PA8598701A1 (es) 2005-02-04
ES2301978T3 (es) 2008-07-01
MXPA05010289A (es) 2005-11-17
NZ542352A (en) 2007-02-23
ATE388173T1 (de) 2008-03-15
HK1078598A1 (en) 2006-03-17
WO2004085500A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
NO20055837D0 (no) Immunsupprimerende forbindelser og sammensetninger
DK1673349T3 (da) Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
DE602004020343D1 (de) Polymere
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
DK1883665T3 (da) Polylactidsammensætninger og anvendelser deraf
DE602005015349D1 (de) Verbesserte kautschukmodifizierte monovinyliden-aromapolymere und daraus hergestellte erzeugnisse
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1620118T3 (da) Reversible pegylerede lægemidler
DE60322020D1 (de) Alkali-quellbare assoziative polymere, methode und zusamensetzungen
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
NO20054135D0 (no) Kipolinon/benzoksazin derivater og anvendelser derav
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
IS7883A (is) Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þau
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1587478T3 (da) Farmaceutisk sammensætning
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf